Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Insulet Corporation $PODD Shares Sold by Allspring Global Investments Holdings LLC
04:08am, Thursday, 23'rd Oct 2025
Allspring Global Investments Holdings LLC lessened its stake in Insulet Corporation (NASDAQ: PODD) by 38.7% during the second quarter, according to the company in its most recent 13F filing with the S
Insulet to Host Investor Day on November 20, 2025
07:00am, Friday, 10'th Oct 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Inv
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:45pm, Tuesday, 07'th Oct 2025
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
10:45am, Monday, 29'th Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally?
09:26am, Friday, 26'th Sep 2025
PODD stock rallies 37.4% in a year, fueled by Omnipod 5 adoption, global launches and expanding reach in diabetes care.
Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
07:00am, Thursday, 18'th Sep 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, and Pantone®, t
Medical device maker Insulet names industry veteran Flavia Pease as CFO
07:25am, Tuesday, 16'th Sep 2025
Medical device maker Insulet said on Tuesday that it appointed industry veteran Flavia Pease as its new chief financial officer and expects to exceed its previously issued third-quarter total revenue
Insulet Announces CFO Transition
07:00am, Tuesday, 16'th Sep 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, toda
Here's Why Insulet (PODD) is a Strong Momentum Stock
10:51am, Monday, 15'th Sep 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
10:45am, Friday, 12'th Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 Transcript
02:31pm, Tuesday, 09'th Sep 2025
Insulet Corporation (NASDAQ:PODD ) Baird Global Healthcare Conference 2025 September 9, 2025 12:15 PM EDT Company Participants Eric Benjamin - Executive VP & COO Ana Chadwick - Executive VP & CFO Conf
Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
06:33pm, Thursday, 04'th Sep 2025
Insulet Corporation (NASDAQ:PODD ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 3:00 PM EDT Company Participants Ashley McEvoy - CEO, President & Director Ana Chadwick - Execut
Here's Why Insulet (PODD) is a Strong Growth Stock
10:45am, Wednesday, 27'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Insulet Elevates Eric Benjamin to Chief Operating Officer
05:00pm, Monday, 25'th Aug 2025
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 25'th Aug 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
